Hunan Warrant PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 5/6
Hunan Warrant PharmaceuticalLtd has a total shareholder equity of CN¥1.9B and total debt of CN¥69.9M, which brings its debt-to-equity ratio to 3.7%. Its total assets and total liabilities are CN¥2.3B and CN¥460.9M respectively. Hunan Warrant PharmaceuticalLtd's EBIT is CN¥183.7M making its interest coverage ratio -13.7. It has cash and short-term investments of CN¥739.8M.
Key information
3.7%
Debt to equity ratio
CN¥69.90m
Debt
| Interest coverage ratio | -13.7x |
| Cash | CN¥739.84m |
| Equity | CN¥1.87b |
| Total liabilities | CN¥460.89m |
| Total assets | CN¥2.33b |
Recent financial health updates
Recent updates
Is Hunan Warrant PharmaceuticalLtd (SHSE:688799) Using Too Much Debt?
Sep 28
Hunan Warrant Pharmaceutical Co.,Ltd's (SHSE:688799) Price Is Right But Growth Is Lacking
Jul 25Should You Be Adding Hunan Warrant PharmaceuticalLtd (SHSE:688799) To Your Watchlist Today?
Jun 14Hunan Warrant Pharmaceutical Co.,Ltd (SHSE:688799) Held Back By Insufficient Growth Even After Shares Climb 26%
Mar 04Financial Position Analysis
Short Term Liabilities: 688799's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥338.9M).
Long Term Liabilities: 688799's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥122.0M).
Debt to Equity History and Analysis
Debt Level: 688799 has more cash than its total debt.
Reducing Debt: 688799's debt to equity ratio has increased from 0.05% to 3.7% over the past 5 years.
Debt Coverage: 688799's debt is well covered by operating cash flow (216.3%).
Interest Coverage: 688799 earns more interest than it pays, so coverage of interest payments is not a concern.